Overview

A Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular

Status:
Terminated

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

The primary outcome measure is to compare efficacy of an association of Secnidazol(2g)-Ciprofloxacin(1g) (during 3 days) versus 3g of Amoxicillin-Clavulanic Acid during 10 days for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among Adults in clinical and biological cure. The cure rate will be evaluated at the second visit (14 days after the inclusion visit)

Phase:

Phase 3

Details

Lead Sponsor:

Quanta Medical

Collaborator:

Laboratoires Iprad-Vegebom

Treatments:

Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Ciprofloxacin
Clavulanic Acid
Clavulanic Acids
Secnidazole